Ionis Pharmaceuticals, Inc.
IONS
$34.30
$1.344.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.72% | -112.00% | 53.60% | -1,441.65% | 93.72% |
| Total Depreciation and Amortization | -4.11% | -1.54% | -1.27% | 0.69% | 0.38% |
| Total Amortization of Deferred Charges | -0.24% | 0.42% | 0.24% | 0.18% | -2.12% |
| Total Other Non-Cash Items | 59.29% | -19.25% | 6.74% | 42.08% | -37.12% |
| Change in Net Operating Assets | -625.68% | 91.00% | -106.56% | -450.53% | 453.07% |
| Cash from Operations | -1.00% | 4.08% | 20.05% | -556.22% | 130.15% |
| Capital Expenditure | -181.55% | -45.27% | -38.75% | -648.60% | 138.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 128.25% | -582.99% | -14.78% | 392.74% | -138.86% |
| Cash from Investing | 120.02% | -645.71% | -17.94% | 384.90% | -138.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -92,702.08% | -23.08% | 0.00% | -2.63% | 99.94% |
| Issuance of Common Stock | -99.91% | 19,009.98% | -89.00% | -42.08% | 992.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -108.89% | 19,299.57% | -89.15% | -42.12% | 226.21% |
| Foreign Exchange rate Adjustments | -238.86% | 1,621.74% | 79.82% | -134.55% | 317.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -327.83% | 173.98% | -8.97% | -206.72% | 164.91% |
